메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87

HANGZHOU, China, Oct. 9, 2025 -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced that it has reached an exclusive commercialization agreement with Huadong Medicine (Hangzhou) Co., Ltd., a wholly owned subsidiary of Huadong Medicine Co., Ltd. (000963.SZ, "Huadong Medicine"), to commercialize CXG87 in Mainland China. Under the terms of the agreement, Chance Pharma, as the MAH (Marketing Authorization Holder), will be res
- 김갑성 기자
- 2025-10-09 17:27
Advantech AOM-5721 Combines SMARC Design and Qualcomm Dragonwing™ QCS6490 for Next-Gen Edge AI

TAIPEI, Oct. 9, 2025 -- Advantech (TWSE: 2395), a global leader in edge computing and AI solutions, is proud to announce the launch of the AOM-5721, a SMARC-based Arm Computer-on-Module powered by the Qualcomm® Dragonwing™ QCS6490 SoC. By combining Advantech's expertise in compact, energy-efficient computing modules with Qualcomm's high-performance SoC, the AOM-5721 delivers cutting-edge AI processing, connectivity, and multimedia capabilities for industrial, commercial, and medical edge applications. Engineered for Intelligent Performance The Qualcomm Dragonwing™ QC
- 김갑성 기자
- 2025-10-09 17:05
BTL, WonderFace 기기 제조사를 상대로 특허 침해 소송 제기

프라하 , 2025년 10월 9일 -- 의료 솔루션 분야를 선도하는 글로벌 기업인 BTL 그룹(BTL Group)은 오늘 WonderFace 기기 제조사인 렉스터 마이크로일렉트로닉 엔지니어링 시스템 S.L(Lexter Microelectronic Engineering Systems S.L)을 상대로 통합 특허 법원에 국제 특허 침해 소송을 제기했다고 발표했다. 이번 소송은 BTL의 EMFACE® 기술 특허에서 시작되었다.1 EMFACE® 기술은 별도의 핸즈-프리 어플리케이터로 선별적 근육 자극과 고주파 가열을 결합하여 안면 리프팅 시술에 혁명을 일으킴으로써 완전히 새로운 안면 시술 카테고리를 열었다는 평가를 얻고 있다. BTL 엔터프라이즈 그룹 CEO 토마스 슈바르츠(Tomas Schwarz)는 "우리는 지적 재산을 단호히 방어하여 고객의 투자를 보호할 계획이다. 이번 소송은 우리의 혁신 기술을 침해하는 제3자를 상대로 법적 소송을 넓혀 나가는 신호탄이 될 것이다."라고 밝혔다. 이번 소송은 WonderFace 시스템이 다수의 국가로 배포되는 것을 막는 데 목적이 있다. 소
- 김갑성 기자
- 2025-10-09 16:01
Herbalgy, the Pain Management Expert, Partners with Heroes in White to Champion a "Pain-Relieving Serenity" Lifestyle

Bringing the Wisdom of Traditional Chinese Medicine into Modern Living HONG KONG, Oct. 9, 2025 -- Following the phenomenal success of TVB's widely acclaimed TV drama Heroes in White—the top-rated series of 2025 with an audience of over 1.57 million and a rating of 24.2 points—Herbalgy, the trusted Pain Management Expert, is extending the show's inspiring message from screen to everyday life. The drama, initiated by TVB, was inspired by the extraordinary real-life experiences of Professor Wong Tin Chee, founder of Herbalgy. Professor Wong's dedication to advancing
- 김갑성 기자
- 2025-10-09 14:18
Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology

[ 메디채널 김갑성 기자 ] The published study results are from the ENLIGHT UC study (ES101002), a multicenter, randomized, double-blind and placebo-controlled Phase III trial of etrasimod conducted across Asia. The study included a 12-week induction phase followed by a 40-week maintenance phase and represents the largest pivotal Phase III study to date in Asian patients with moderately to severely active ulcerative colitis. The study results showed that, during both the 12-week induction phase and the 40-week maintenance phase, etrasimod demonstrated statistically significant and clinically meaningf
- 김갑성 기자
- 2025-10-09 13:10
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025

RIO DE JANEIRO, Oct. 9, 2025 -- Anbio Biotechnology participated in the 50th World Small Animal Veterinary Association Congress (WSAVA 2025), an international gathering that brought together veterinarians, researchers, and industry representatives from more than 100 countries. The event provided a platform for Anbio to present its veterinary diagnostic portfolio and exchange views with partners across global markets. At WSAVA 2025, Anbio displayed five product lines: Fluorescence Immunoassay (FIA) Dry Chemistry Molecular Diagnostics Colloidal Gold Rapid Tests Dry Chem
- 김갑성 기자
- 2025-10-09 11:41
Neopharma Technologies Appoints Singapore Fintech Veteran and Serial Entrepreneur Mr. Joo Seng Wong as Board Advisor to Oversee Institutional Strategy and Global Execution

SINGAPORE, Oct. 9, 2025 -- Neopharma Technologies Ltd ("Neopharma"), a digital health company pioneering AI-driven Digital Drug and Impairment Testing, today announced the appointment of Mr. Joo Seng Wong to its Advisory Board. Mr. Wong will play a key role in strengthening Neopharma's institutional strategy, execution frameworks, and global commercialization roadmap as the company advances toward its planned NASDAQ listing. Institutional Credibility and Strategic Depth Mr. Wong is one of Singapore's most accomplished financial and technology lead
- 김갑성 기자
- 2025-10-09 09:58
EDAN Expands U.S. Operations with New Manufacturing Hub

Facility marks EDAN's 30th anniversary and kickstarts global supply chain ecosystem SAN DIEGO, Oct. 9, 2025 -- Edan Instruments, Inc. (300206.SZ), a global leader in medical device innovation, announced the official opening of its new U.S. manufacturing hub in San Diego, California, on September 30, 2025. Building on more than 15 years of local presence through its San Diego office, the milestone marks EDAN Diagnostics, Inc.'s first U.S.-based production site and strengthens the company's presence in the region, enhancing its ability to support healthcare providers with advance
- 김갑성 기자
- 2025-10-09 06:53
명상이 정량화 가능한 성과가 되는 시대 -- 일본 최초의 '정량화 명상 챌린지'

도쿄, 2025년 10월 8일 -- 세계명상연맹(World Meditation League•WML)과 올히어(All Here)가 일본 도쿄 핫포엔(Happo-en) 정원에서 일본 최초의 도쿄 정량화 명상 챌린지(Tokyo Quantified Meditation Challenge)를 선보이며 명상이 새로운 시대에 접어들었다. 이와 같은 전례 없는 행사는 명상을 개인의 내면 성찰에서 벗어나 신경과학을 통해 측정과 관찰이 가능한 경쟁적인 분야로 변화시켰다. 행사에서 참가자의 두뇌 활동, 집중도, 자기 인식, 내면의 고요가 정량화된 데이터로 화면에 시각적으로 표시되자 관객들은 처음으로 명상의 효과를 실시간으로 목격했다. 기술 × 건축 × 자연 — 쿠마 겐고와 올히어가 개발한 명상 캡슐 공개 오후 행사는 세계적으로 유명한 건축가 쿠마 겐고(Kengo Kuma)의 발표로 시작됐다. 그는 올히어가 개발한 몰입형 명상 XR 플랫폼 젠부 코코(Zenbu Koko)를 공개했다. 쿠마 겐고는 "나는 오래전부터 건축, 공허함, 자연을 매끄럽게 연결하고 싶었다
- 김갑성 기자
- 2025-10-09 04:59
Breakthrough Lectures to Headline the 2025 World Congress of Neurology in Seoul

SEOUL, South Korea, Oct. 9, 2025 -- The World Federation of Neurology (WFN) and the Korean Neurological Association (KNA) will host the XXVII World Congress of Neurology (WCN) in Seoul, South Korea, from Oct. 12-15, 2025. WCN is a major, biennial conference that brings together world-class neurologists, experts, researchers, and clinicians from across the globe to showcase the latest advances in brain science, neurology, and patient care. The congress theme, "The Soul of Neurological Innovation," is exemplified through an elite Scientific Program featuring some of the
- 김갑성 기자
- 2025-10-09 04:41

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-10-19_SUN

2025-10-18_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 19일 03시 20분